Schedule 13G ownership disclosure

RTI Biologics, Inc.

Security class unavailable · CUSIP: 74975N105

Event date: 2020-04-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,714,924
Percent of class
5.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000846087-20-000052
Form type
SC 13G
Filer
SURGALIGN HOLDINGS, INC.
CIK
CIK 1760173
Filed
Apr 13, 2020
Reporting period
Apr 02, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub